In atopic dermatitis, H1 antihistamines do not provide a clinically important reduction in itch or disease severity.

In atopic dermatitis, H1 antihistamines do not provide a clinically important reduction in itch or disease severity.

• Why it matters: Itch and visible symptoms in atopic dermatitis drive quality-of-life impairment, but the clinical value of H1 antihistamines for symptom relief is uncertain.
• What they did: A clinical evaluation assessed whether H1 antihistamines reduce itch and overall disease severity in people with atopic dermatitis.
• The result: The findings indicate no clinically important improvement in itch or disease severity, suggesting limited therapeutic benefit for these outcomes in this condition.

AI summary of the abstract · may contain errors · not medical advice · read the paper.